Navigation Links
Accenx Technologies Joins Sun's Authorized Subcontractor Program
Date:5/22/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
... research shows smoking actually helps arteries st...ood vessels in the legs.Researchers // who conduct...t say the findings suggest the increased level of ...be beneficial in preventing restenosis, or re-narr...
... prostate specific antigen level is a marker to he...hers conducted a study to determine //the prevalen... of four or less. Data was used from the Prostate ... in the trial, 2,950 men never had a PSA level of ...
...ew study shows pregnant women with asthma can redu...ng oily fish. Results show asthmatic // mothers wh...pregnancy were about 70-percent less likely to hav...the more oily fish a woman consumed, the less like...
...ording to findings from a recent study researchers...ve a modern medical application. Lymphoma patients...leep quality than those in a control group. The st...ents who were either undergoing treatment or who h...
Other Medicine News:
(Date:9/4/2008)...ication for Targeted Therapies That E...GTON BEACH, Calif., and AMSTERDAM, Netherlands, Se...olecular cancer diagnostics,today announced the l...t,allows physicians to quantitatively determine th...(ER), progesterone receptor (PR) and Human Epiderm...
(Date:9/3/2008)... Research and Education Foundation,s Within Our R...ting, Treating and Understandi...irst time during its,unprecedented initiative to f...College of Rheumatology Research and Education Fou... research funded by the Within Our,Reach: Finding ...
(Date:9/3/2008)...(dronedarone) decreased the risk of,stroke by 34% ...ter already adequately treated by ant...- The results of a,post-hoc...resented today at,the clinical trial update sessio...008, in Munich, Germany. Previous results from the...
(Date:9/3/2008)...re-FirstCall/ -- A sub-analysis of,the TRITON-TIMI...ugrel,compared with clopidogrel significantly redu...4 percent vs. 9.7 percent, p<0.0001), regardless,o...n artery-opening,procedure known as percutaneous c...ontaneously during the longer-term maintenance pha...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6New chemotherapy combo produces side effects but no extra efficacy in early breast cancer patients 2933 1New chemotherapy combo produces side effects but no extra efficacy in early breast cancer patients 2933 2Vobile Launches VideoDNA Live 3B Enables Real Time Digital Content Protection for Live Broadcast Events 2931 1Vobile Launches VideoDNA Live 3B Enables Real Time Digital Content Protection for Live Broadcast Events 2931 2Vobile Launches VideoDNA Live 3B Enables Real Time Digital Content Protection for Live Broadcast Events 2931 3Young Boy With Epilepsy to Gain Independence With New Seizure Response Dog From Canine Assistants 17058 1Young Boy With Epilepsy to Gain Independence With New Seizure Response Dog From Canine Assistants 17058 2Womens Sports Foundation Hosted The Billies Recognizing Media Excellence in Womens Sports and Physical Activity 17053 1Womens Sports Foundation Hosted The Billies Recognizing Media Excellence in Womens Sports and Physical Activity 17053 2Womens Sports Foundation Hosted The Billies Recognizing Media Excellence in Womens Sports and Physical Activity 17053 3
...swire/ -- Phase 3 results,from the RE-NOVATE(TM) t...nce daily, administered for an average of 33 days,... for an average of 33,days, in preventing venous t... total hip replacement surgery. In this trial, the... etexilate was,similar to enoxaparin. The incidenc...
...2007 - The Journal of the,American Society of Clin... clinical study conducted by Dr. Siu-Fun Wong, and...gel, Regenecare(R),caused a statistically signifi...hat results from the use of anti-cancer drugs,know... trial is,listed on the National Cancer Institute ...
Other Medicine Technology:Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5Clinical Study Shows Regenecare Relieves Pain and Itching of Skin,Rashes Caused by Widely Used Cancer Drugs 2
Tennant straight tying forceps with extra delicate smooth jaws, 6 mm tying platform, For 9-0 to 11-0 sutures. Overall length 108 mm.
Kelman - McPherson angled tying forceps is long with tying platform 10 mm, serrated handle and polished finish.
Castroviejo tying forceps, straight.
Gerl titanium tying forceps has curved shanks, smooth jaws and 6 mm long tying platform. For 8-0 to 11-0 sutures.
Medicine Products: